Signature Genomic Laboratories, LLC And Affymetrix (Bedford, Massachusetts) Sign License Agreement

Signature Genomic Laboratories, LLC(R) today announced that it has entered into a license agreement with Affymetrix, Inc. (NASDAQ:AFFX). The non-exclusive, worldwide license is for a number of Affymetrix patents related to the use of microarrays for comparative genomic hybridization analysis. The license will be applied to Signature Genomics' SignatureChip(R) microarray-based diagnostics for cytogenetic abnormalities. Details of the license were not disclosed.